Abstract

Does allergen immunotherapy impact the susceptibility and severity of COVID-19?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Compliance and safety evaluation of subcutaneous versus sublingual immunotherapy in mite-sensitized patients with allergic rhinitis
Liang Zhu ... Yu-Lin Wu
Chinese journal of otorhinolaryngology head and neck surgery | VOL. 45
Liang Zhu, et. al.Liang Zhu ... Yu-Lin Wu
01 Jun 2010
A Randomized Trial of Subcutaneous Allergy Immunotherapy in Inner-city Children With Asthma Less Than 4 Years of Age
Alicia Augustin Alvarez ... Jeffrey Chambliss
Pediatrics | VOL. 148
Alicia Augustin Alvarez, et. al.Alicia Augustin Alvarez ... Jeffrey Chambliss
01 Dec 2021
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement.
Tari Haahtela ...
Allergy | VOL. 75
Tari Haahtela, et. al.Tari Haahtela ...
01 Jul 2020
Immunization Update 2021
Miranda Wilhelm
Pharmacy Today | VOL. 27
Miranda WilhelmMiranda Wilhelm
01 Aug 2021
View more papers

More From: Clinical and translational allergy

Paper Title
Journal
Date
Author
Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK-air study.
Bernardo Sousa-Pinto ...
Clinical and translational allergy | VOL. 14
Bernardo Sousa-Pinto, et. al.Bernardo Sousa-Pinto ...
01 Jun 2024
-
-
Clinical and Translational Allergy | VOL. 14
--
01 Jun 2024
Issue Information
-
Clinical and Translational Allergy | VOL. 14
--
28 May 2024
Proteomic analysis reveals potential therapeutic targets for childhood asthma through Mendelian randomization.
Yi‐Qing Wu ... Zhen‐Lang Lin
Clinical and translational allergy | VOL. 14
Yi‐Qing Wu, et. al.Yi‐Qing Wu ... Zhen‐Lang Lin
01 May 2024
View more papers